Review On: Liquid Crystal Cream for Topical Drug Delivery

Year : 2024 | Volume :11 | Issue : 01 | Page : 1-8
By

Bhupendra M. Mahale

Sandip A.Tadavi

Sunil P. Pawar

  1. Research Scholar Kavayitri Bahinabai Chaudhari NMU University, P.S.G.V.P. Mandal’s College of Pharmacy Maharashtra India
  2. Associate Professor Kavayitri Bahinabai Chaudhari NMU University, P.S.G.V.P. Mandal’s College of Pharmacy Maharashtra India
  3. Principal P.S.G.V.P. Mandal’s College of Pharmacy Maharashtra India

Abstract

A Liquid crystal creams represent a novel approach in skincare formulations, leveraging the unique properties of liquid crystal technology to improve skin hydration and barrier function. An overview of current developments in liquid crystal cream formulations is given in this article, with an emphasis on the benefits they offer for skincare and their composition and structure. Liquid crystal creams mimic the lipid bilayers of the skin, offering enhanced compatibility and permeability. Liquid crystal creams have emerged as a promising vehicle for topical drug delivery in pharmaceutical formulations, offering unique advantages for enhancing drug permeation, stability, and efficacy. This comprehensive review explores the application of liquid crystal technology in topical drug delivery systems, with a focus on composition, structure, and therapeutic applications. Liquid crystal creams, by mimicking the organization of biological membranes, facilitate the penetration of drugs across the skin barrier, resulting in improved bioavailability and therapeutic outcomes. Their versatile composition allows for the incorporation of à wide range of drugs, including hydrophilic and lipophilic compound, peptides, and proteins, enabling targeted delivery to specific skin layers or underlying tissues. Furthermore, the rheological properties of liquid crystal creams can be tailored to optimize drug release kinetics, providing sustained and controlled drug delivery over extended periods. Additionally, the incorporation of penetration enhancers and other excipients into liquid crystal creams can further enhance drug permeation and tissue targeting, expanding their potential applications in dermatology, cosmeceuticals, and wound healing. This review highlights the potential of liquid crystal creams as versatile and effective platforms for topical drug delivery in pharmaceutical formulations, with opportunities for continued research and development to optimize their performance and clinical utility.

Keywords: Liquid crystal, Cream, Skin, Topical drug delivery, Penetration, Bioavailability.

[This article belongs to Trends in Drug Delivery(tdd)]

How to cite this article: Bhupendra M. Mahale, Sandip A.Tadavi, Sunil P. Pawar. Review On: Liquid Crystal Cream for Topical Drug Delivery. Trends in Drug Delivery. 2024; 11(01):1-8.
How to cite this URL: Bhupendra M. Mahale, Sandip A.Tadavi, Sunil P. Pawar. Review On: Liquid Crystal Cream for Topical Drug Delivery. Trends in Drug Delivery. 2024; 11(01):1-8. Available from: https://journals.stmjournals.com/tdd/article=2024/view=144679





References

1. Kelker, H., and Hatz, R., Handbook of Liquid Crystals, Verlag Chemie, Weinheim, Germany,1980. 2. De Gennes PG, Prost J. The physics of liquid crystals. Oxford university press; 1993.
3. Mahajan Jyotsna, Lyotropic Liquid Crystalline System For Effective Topical Delivery of Tolnaftate, Asian Journal of Pharmaceutical research and Development. 2018;6 (3):75–80
4. Encyclopedia of Pharmaceutical Technology. Editors: James Swarbrick, James C. Boylan. Volume 20, page no 117
5. Reinitzer, F., Beitra¨ge zur Kenntnis des Cholesterins, Monatsh. Chem., 9:412–441 (1888).
6. Silver, B., ed., The Physical Chemistry of Membranes, Allen & Unwin, Inc., & Solomon Press, Winchester, MA, 1985.
7. Schuetze, W., and Mueller-Goymann, C.C., Mutual interactions between nonionic surfactants and gelatin—investigations in cubic liquid crystalline systems and micellar systems, Colloid Polym. Sci., 269:85–90 (1992).
8. Fu ¨hrer, C., Junginger, H., and Friberg, S., Structural studies of ointments. Part 1: X-ray struc ture studies on the hydrophilic ointment DAB 7, J. Soc. Cosmet. Chem., 29:703–716 (1978).
9. Euschen, A., Diffusion in flu ¨ssigkristallinen Silastomeren—ein Beitrag zur Kontrolle der Arz neistofffreisetzung durch Diffusion, Ph.D. Thesis, Universita ¨t des Saarlandes, Saarbru ¨cken, Germany, 1986.
10. Tiemessen, H.L.G.M., Nonionic Surfactant Systems for Transdermal Drug Delivery, Ph.D. Thesis Leiden University, The Netherlands, 1989.
11. Pallavi Kawara, Vishal Pande, Liquid Crystals: A Novel Approach Drug Delivery System, JETIR June, 2019, Volume-6,402–410.
12. Shaikh Zeba, Liquid Crystalline System: A Novel approach for Drug Delivery, Journal of Biomedical and Pharmaceutical Research 4 (1) 2015, 22–32.
13. Savita Mandan, Maitreyee Chavan, Cubosomes: Future of Therapeutics, International journal of pharmacy and pharmaceutical research, March 2020 Vol.:17, Issue: 4, 60–69.
14. Yogeshvar Tyagi, liquid crystal: An approach to different states of Matter, Pharma innovation journal, 2018, 7(5): 540–545.
15. Kawamoto H. The history of liquid crystal display. Proceedings of the IEEE, 460–99, 2002
16. V. Viswanatha, C. Rajaramb, S. R. Fathimac, D. Bhanu Priyad, Brief Review of Liquid Crystals, International Journal of Trend in Scientific Research and Development (IJTSRD), 2018, Volume-2,956–961.

17. Acciacca A, Spong BR, Fleisher D, Hornedo NR. Mol. Pharmaceutics, 5: 956–967(2008).
18. Rebecca J. Carlton, Jacob T. Hunter, Daniel S. Miller, Reza Abbasi, Peter C. Mushenheim, Lie Na Tan, and Nicholas L. Abbott, Chemical and biological sensing using liquid crystals, Liq Cryst Rev, 2013; 1(1): 29–51.
19. Tzeng CW, Abbott DE, Cantor SB et al. (2013) Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis.’ Ann Surg Oncol 20(Suppl 3): 2197–203.
20. Patel PV, Patel JB, Dangar RD, Patel KS, Chauhan KN. Liquid crystal drug delivery system. International Journal of Pharmaceutical and Applied Sciences. 2010;1(1):118–23.
21. Myers G, inventor; Fuisz Technologies Ltd, assignee. Drug delivery systems utilizing liquid crystal structures. United States patent US 5,891,845. 1999 Apr 6.
22. Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B, Faurisson F, Rouveix B. Controlled release of vancomycin from poloxamer 407 gels. Int J Pharm. 1999 Dec 10;192(2):183–93. doi: 10.1016/s0378-5173(99)00307-5.
23. Seideman T. The liquid-crystalline blue phases. Reports on Progress in Physics. 1990 Jun 1;53(6):659.
24. Gan L, Wang J, Jiang M, et al. Recent advances in topical ophthalmic drug delivery with lipid based nanocarriers. Drug Discov Today 2013;18(5-6): 290–7.
25. Gan L, Han S, Shen J, et al. Self-assembled liquid crystalline nanoparticles as a novel ophthalmic delivery system for dexamethasone: improving preocular retention and ocular bioavailability. Int J Pharm 2010; 396(1-2):179–87
26. Tadwee I, Shahi S, Ramteke V, Syed I. Liquid crystals pharmaceutical application: A review. Int. J. Pharm. Res. Allied Sci. 2012;1(2):6–11.
27. Liquid crystals containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions. Gheorge Cioca, Lake Grove, James Hayward, Port jeffeson, Manuel L. Tan, Glen Clove, Morris Herstein scarsdae, N.Y.walter, Stamford, conn. s.l. US 4,999,348, March 12, 1991.
28. S. Murgia S, Bonacchi S, Falchi AM, Lampis S, Lippolis V, Meli V, Monduzzi M, Prodi L, Schmidt J, Talmon Y, Caltagirone C. Drug-loaded fluorescent cubosomes: versatile nanoparticles for potential theranostic applications. Langmuir. 2013 Jun 4;29(22):6673–9.
29. Imran Tadwee, Dr.Sadhana Shahi, Vivek Ramteke, Iftequar Syed, Liquid Crystals Pharmaceutical Application: A Review, IJPRAS, Volume 1, issue2 (2012), 06–11.
30. Rego, J.A.; Harvey, Jamie A.A.; MacKinnon, Andrew L.; Gatdula, Elysse (January 2010). “Asymmetric synthesis of a highly soluble ‘trimeric’ analogue of the chiral nematic liquid crystal twist agent Merck S1011”. Liquid Crystals37 (1): 37–43. doi:10.1080 /02678290903359291.
31. Boyd BJ, Whittaker D V, Khoob S, DaveyG. Hexosome formed from glycerate surfactants Formulation as a colloidal carrier for irinotecan.Internationa Journal of Pharmaceutics, 318: 154–162(2006).
32. Zahra Karami and Mehrdad Hamidi, Cubosomes: remarkable drug delivery potential, Drug Discovery Today, Volume 5, Number 5, 790–799, May 2016.
33. Lehn JM, Giuseppone N, Herrmann A, inventors; Firmenich SA, Centre National de la Recherche Scientifique CNRS, Universite Louis Pasteur Strasbourg I, assignee. Imine based liquid crystals for the controlled release of bioactive materials. United States patent US 8,158,135. 2012 Apr 17.
34. Nesseem DI. Formulation and evaluation of itraconazole via liquid crystal for topical delivery system. Journal of pharmaceutical and biomedical analysis. 2001 Oct 1;26(3):387–99.
35. Bunma N, Moungjaroen J, Tanguenyongwatana P. DEVELOPMENT OF GARCINIA MANGOSTANA EXTRACT IN LIQUID CRYSTAL CREAM FOR TOPICAL DELIVERY SYSTEM. The Thai Journal of Pharmaceutical Sciences. 2013;38:177–9.
36. Jarupinthusophon S, Preechataninrat P, Anurukvorakun O. Development of Liquid Crystal Cream Containing Germinated Brown Rice. Applied Sciences. 2022 Nov 2;12(21):11113.


Regular Issue Subscription Review Article
Volume 11
Issue 01
Received March 14, 2024
Accepted April 1, 2024
Published April 30, 2024